Weight Loss Injections

Weight Management Programme – Patient Information

Our practice is taking part in a phased NHS weight management programme, which is being rolled out nationally over several years. Access to the programme is based on specific eligibility criteria, including body mass index (BMI) and certain long‑term health conditions.

From June 2026, the programme moves into Year 2, meaning a new group of patients may become eligible. This page explains who can be considered during this phase, how eligibility is assessed, and what to expect if you are identified.

Please be aware that the programme has limited capacity and patients who meet the criteria will be contacted directly by the practice. Unfortunately, we are unable to accept self‑referrals or offer the programme outside the nationally set criteria.

Who will be eligible to get Tirzepatide (Mounjaro) on the NHS?

From June 2026 to March 2027, access to the next phase of the NHS weight management programme will be offered to a new group of patients, based on national eligibility criteria.

Who is eligible in Year 2?
During this phase (called Cohort II), patients may be considered if they:

  • Have a BMI between 35 and 39.9, and have four or more of the following long-term health conditions:
  • High blood pressure (hypertension)
  • High cholesterol (dyslipidaemia)
  • Obstructive sleep apnoea
  • Cardiovascular disease (heart or vascular conditions)
  • Type 2 diabetes

Important information about BMI: For people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African‑Caribbean backgrounds, eligibility may apply at a lower BMI threshold (usually 2.5 kg/m² lower), in line with national guidance.

How will patients be contacted?
Eligible patients will be identified and contacted directly by the practice. Please note that places are limited and meeting the criteria does not automatically guarantee enrolment.

If you think you may be eligible, there is no need to contact the practice at this stage. We will be in touch if you are identified as meeting the criteria.

What if I'm not eligible for Mounjaro or the Specialist Weight Management Service?

If you’re not eligible for Mounjaro, there are still plenty of effective NHS and community options to help you manage your weight and improve your health. These include:

Self-guided support tools:

  • NHS Weight Loss Plan App
  • NHS Couch to 5K running programme
  • NHS Active 10 Walking Tracker
  • NHS Food Scanner to help with healthy food choices

Health and lifestyle support:

  • NHS Health Checks – includes weight advice and screening for other health conditions
  • Diet and exercise advice 
  • Local council-run weight programmes 

Referred NHS services:

  • NHS Digital Weight Management Programme – for adults with a BMI over 30 who also have Type 1 or 2 diabetes or high blood pressure. Ask your GP for a referral.
  • Diabetes Prevention Programme – for adults with pre-diabetes. 
  • DESMOND – for people with Type 2 diabetes. 
  • Path to Type 2 Diabetes Remission – where available
  • NHS Specialist Weight Management Services – for people with:
    • A BMI of 35–39.9 and at least one obesity-related health condition
    • OR a BMI of 40 or above

Need help deciding what’s right for you?

For weight loss services requiring a referral, excluding weight loss injections at this time, you can talk to your GP or healthcare team. They can help you understand your eligibility and options and refer you to the right support. 

Important Information: Weight Loss Injections taken with Contraception and HRT

Important Information: GLP-1 Medications and Hormone Treatments

If you are taking GLP-1 receptor agonists (such as semaglutide, liraglutide, or others), it's important to know how these medications might affect hormonal treatments, including contraception and hormone replacement therapy (HRT).

Oral Contraception

GLP-1 medications may reduce the absorption of oral contraceptives. This can lower their effectiveness and increase the risk of unplanned pregnancy.

What you should do:

  • Consider using a non-oral form of contraception (e.g., condoms, patch, injection, implant, or IUD), especially when starting or increasing the dose of a GLP-1 medicine.
  • Speak with your healthcare provider about the most suitable contraception option for you.

----------------------------------------------------------------------

Oral Progesterone (Used in HRT)

GLP-1 medications may also affect the absorption of oral progesterone, which is commonly used as part of hormone replacement therapy (HRT).

What you should do:

  • If you are taking oral progesterone for HRT and start or increase a GLP-1 medication, your dose may need to be adjusted.
  • Do not change your medication on your own — always consult your doctor or menopause specialist.

If you have any questions or concerns regarding your contraception or HRT, please don’t hesitate to contact the practice.

Page last reviewed: 12 May 2026
Page created: 19 June 2025